UK markets closed

Aethlon Medical, Inc. (AEMD)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.3900+0.0350 (+2.58%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.66M
Enterprise value -3.31M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.88
Price/book (mrq)0.48
Enterprise value/revenue -5.76
Enterprise value/EBITDA 0.27

Trading information

Stock price history

Beta (5Y monthly) 1.94
52-week change 3-60.86%
S&P500 52-week change 322.38%
52-week high 35.0000
52-week low 31.3000
50-day moving average 31.6204
200-day moving average 32.0740

Share statistics

Avg vol (3-month) 38.39k
Avg vol (10-day) 38.35k
Shares outstanding 52.63M
Implied shares outstanding 62.63M
Float 82.41M
% held by insiders 16.44%
% held by institutions 11.99%
Shares short (15 Apr 2024) 429.76k
Short ratio (15 Apr 2024) 42.95
Short % of float (15 Apr 2024) 41.15%
Short % of shares outstanding (15 Apr 2024) 41.13%
Shares short (prior month 15 Mar 2024) 49.9k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 315 Oct 2019
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 305 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,047.16%

Management effectiveness

Return on assets (ttm)-47.16%
Return on equity (ttm)-98.43%

Income statement

Revenue (ttm)574.25k
Revenue per share (ttm)0.24
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -11.4M
Net income avi to common (ttm)-12.25M
Diluted EPS (ttm)-5.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.97M
Total cash per share (mrq)3.04
Total debt (mrq)1.01M
Total debt/equity (mrq)13.27%
Current ratio (mrq)3.93
Book value per share (mrq)2.93

Cash flow statement

Operating cash flow (ttm)-10.51M
Levered free cash flow (ttm)-5.87M